Teleflex Net Acquisitions/Divestitures 2010-2025 | TFX
Teleflex annual/quarterly net acquisitions/divestitures history and growth rate from 2010 to 2025. Net acquisitions/divestitures can be defined as the total change in cash resulting from both investments in businesses and sales of businesses or business segments.
- Teleflex net acquisitions/divestitures for the quarter ending March 31, 2025 were $0.000B, a 28.57% increase year-over-year.
- Teleflex net acquisitions/divestitures for the twelve months ending March 31, 2025 were $0.000B, a 99.93% decline year-over-year.
- Teleflex annual net acquisitions/divestitures for 2024 were $-0B, a 99.98% decline from 2023.
- Teleflex annual net acquisitions/divestitures for 2023 were $-0.589B, a 216.63% increase from 2022.
- Teleflex annual net acquisitions/divestitures for 2022 were $-0.186B, a 184.42% decline from 2021.
| Teleflex Annual Net Acquisitions/Divestitures (Millions of US $) |
|
|---|---|
| 2024 | $0 |
| 2023 | $-589 |
| 2022 | $-186 |
| 2021 | $220 |
| 2020 | $-766 |
| 2019 | $-3 |
| 2018 | $-117 |
| 2017 | $-1,762 |
| 2016 | $-4 |
| 2015 | $-93 |
| 2014 | $-41 |
| 2013 | $-309 |
| 2012 | $-303 |
| 2011 | $351 |
| 2010 | $181 |
| 2009 | $314 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $5.181B | $3.047B |
| Teleflex is a global provider of medical technology products. The company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company markets and sells its products to hospitals and healthcare providers worldwide through a combination of direct sales force and distributors. Teleflex has manufacturing operations located in the Czech Republic, Germany, Malaysia, Mexico and the United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $179.908B | 74.58 |
| Thermo Fisher Scientific (TMO) | United States | $176.180B | 21.32 |
| Alcon (ALC) | Switzerland | $45.487B | 30.74 |
| Edwards Lifesciences (EW) | United States | $45.115B | 29.58 |
| IDEXX Laboratories (IDXX) | United States | $43.483B | 49.97 |
| DexCom (DXCM) | United States | $33.890B | 52.38 |
| IQVIA Holdings (IQV) | United States | $33.021B | 18.66 |
| Mettler-Toledo (MTD) | United States | $26.128B | 31.07 |
| STERIS (STE) | Ireland | $22.180B | 24.43 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.745B | 0.00 |
| Waters (WAT) | United States | $17.593B | 24.82 |
| Hologic (HOLX) | United States | $14.697B | 15.97 |
| Sysmex ADR (SSMXY) | Japan | $10.821B | 30.70 |
| Penumbra (PEN) | United States | $9.038B | 70.94 |
| Masimo (MASI) | United States | $8.946B | 33.00 |
| Globus Medical (GMED) | United States | $7.316B | 17.43 |
| Glaukos (GKOS) | United States | $5.485B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.039B | 21.17 |
| TransMedics (TMDX) | United States | $3.720B | 80.86 |
| PROCEPT BioRobotics (PRCT) | United States | $3.323B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.406B | 14.32 |
| Nihon Kohden (NHNKY) | Japan | $2.154B | 24.71 |
| Elekta AB (EKTAY) | Sweden | $1.952B | 17.55 |
| Veracyte (VCYT) | United States | $1.896B | 26.60 |
| Alphatec Holdings (ATEC) | United States | $1.583B | 0.00 |
| Artivion (AORT) | United States | $1.334B | 124.96 |
| OPKO Health (OPK) | United States | $1.134B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.076B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.021B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.995B | 5.29 |
| SiBone (SIBN) | United States | $0.757B | 0.00 |
| IRadimed (IRMD) | United States | $0.725B | 36.77 |
| Beta Bionics (BBNX) | United States | $0.640B | 0.00 |
| AxoGen (AXGN) | United States | $0.613B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.575B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.560B | 8.71 |
| Semler Scientific (SMLR) | United States | $0.542B | 11.67 |
| Pacific Biosciences Of California (PACB) | United States | $0.507B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.451B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.411B | 9.54 |
| Delcath Systems (DCTH) | United States | $0.404B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.382B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.374B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.324B | 0.00 |
| RxSight (RXST) | United States | $0.321B | 0.00 |
| NeuroPace (NPCE) | United States | $0.312B | 0.00 |
| Neuronetics (STIM) | United States | $0.294B | 0.00 |
| 908 Devices (MASS) | United States | $0.263B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.255B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.244B | 14.76 |
| CVRx (CVRX) | United States | $0.224B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.205B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.195B | 0.00 |
| Inogen (INGN) | United States | $0.181B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.166B | 0.00 |
| LENSAR (LNSR) | United States | $0.155B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.151B | 0.00 |
| Accuray (ARAY) | United States | $0.145B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.121B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.119B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.115B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.103B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.089B | 0.00 |
| Hyperfine (HYPR) | United States | $0.087B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.20 |
| InspireMD (NSPR) | United States | $0.076B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.072B | 0.00 |
| Spectral AI (MDAI) | United States | $0.063B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.055B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.055B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.051B | 20.78 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| Envoy Medical (COCH) | United States | $0.034B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.015B | 0.00 | |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.54 |